ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis
USA - NASDAQ:OSUR - US68554V1089 - Common Stock
2.27 USD
+0.16 (+7.58%)
2.27 USD
0 (0%)
Taking everything into account, OSUR scores 2 out of 10 in our fundamental rating. OSUR was compared to 188 industry peers in the Health Care Equipment & Supplies industry. OSUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OSUR does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
OSUR had negative earnings in the past year.
In the past year OSUR has reported a negative cash flow from operations.
In the past 5 years OSUR reported 4 times negative net income.
In multiple years OSUR reported negative operating cash flow during the last 5 years.
1.2 Ratios
OSUR has a Return On Assets (-14.24%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -16.64%, OSUR is in the better half of the industry, outperforming 62.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROIC | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OSUR has a worse Gross Margin (40.41%) than 66.49% of its industry peers.
In the last couple of years the Gross Margin of OSUR has declined.
The Profit Margin and Operating Margin are not available for OSUR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
2. Health
2.1 Basic Checks
OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OSUR has more shares outstanding
OSUR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OSUR has an improved debt to assets ratio.
2.2 Solvency
OSUR has an Altman-Z score of 1.49. This is a bad value and indicates that OSUR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.49, OSUR perfoms like the industry average, outperforming 56.38% of the companies in the same industry.
OSUR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of OSUR (0.00) is better than 74.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.49 |
ROIC/WACCN/A
WACC8.73%
2.3 Liquidity
A Current Ratio of 7.03 indicates that OSUR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.03, OSUR belongs to the top of the industry, outperforming 86.70% of the companies in the same industry.
A Quick Ratio of 6.20 indicates that OSUR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 6.20, OSUR belongs to the top of the industry, outperforming 87.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 |
3. Growth
3.1 Past
The earnings per share for OSUR have decreased strongly by -633.33% in the last year.
Looking at the last year, OSUR shows a very negative growth in Revenue. The Revenue has decreased by -43.95% in the last year.
Measured over the past years, OSUR shows a small growth in Revenue. The Revenue has been growing by 3.75% on average per year.
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
3.2 Future
The Earnings Per Share is expected to grow by 25.37% on average over the next years. This is a very strong growth
Based on estimates for the next years, OSUR will show a decrease in Revenue. The Revenue will decrease by -4.62% on average per year.
EPS Next Y-241.31%
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OSUR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OSUR's earnings are expected to decrease with -41.36% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
5. Dividend
5.1 Amount
OSUR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.27
+0.16 (+7.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners92.79%
Inst Owner Change-1.46%
Ins Owners4.8%
Ins Owner Change2.83%
Market Cap166.03M
Revenue(TTM)125.70M
Net Income(TTM)-60.24M
Analysts82.5
Price Target6.12 (169.6%)
Short Float %5.47%
Short Ratio7.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.19%
Min EPS beat(2)-24.34%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-41.25%
Min EPS beat(4)-142.2%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-77.07%
EPS beat(12)8
Avg EPS beat(12)182.53%
EPS beat(16)9
Avg EPS beat(16)134.8%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.84%
Max Revenue beat(2)0.89%
Revenue beat(4)2
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-8.84%
Max Revenue beat(4)0.89%
Revenue beat(8)6
Avg Revenue beat(8)-0.34%
Revenue beat(12)10
Avg Revenue beat(12)7.45%
Revenue beat(16)14
Avg Revenue beat(16)8.57%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)2.63%
EPS NQ rev (3m)-27.59%
EPS NY rev (1m)-3.57%
EPS NY rev (3m)-16.78%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.32 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.46 | ||
| P/tB | 0.55 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS1.72
BVpS4.95
TBVpS4.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% | ||
| FCFM | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score2
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 36.29% | ||
| Cap/Sales | 2.97% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 | ||
| Altman-Z | 1.49 |
F-Score2
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y-241.31%
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
EBIT growth 1Y-539.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-100.55%
EBIT Next 3Y14.36%
EBIT Next 5Y25.91%
FCF growth 1Y-157.36%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-148.56%
OCF growth 3YN/A
OCF growth 5Y22.81%
ORASURE TECHNOLOGIES INC / OSUR FAQ
What is the ChartMill fundamental rating of ORASURE TECHNOLOGIES INC (OSUR) stock?
ChartMill assigns a fundamental rating of 2 / 10 to OSUR.
Can you provide the valuation status for ORASURE TECHNOLOGIES INC?
ChartMill assigns a valuation rating of 0 / 10 to ORASURE TECHNOLOGIES INC (OSUR). This can be considered as Overvalued.
Can you provide the profitability details for ORASURE TECHNOLOGIES INC?
ORASURE TECHNOLOGIES INC (OSUR) has a profitability rating of 1 / 10.
How financially healthy is ORASURE TECHNOLOGIES INC?
The financial health rating of ORASURE TECHNOLOGIES INC (OSUR) is 5 / 10.